Litigating Patents in Investment Arbitration: Eli Lilly v. Canada

Details

Author(s):
Publish Date:
October 1, 2017
Publication Title:
Journal of Intellectual Property Law & Practice
Format:
Journal Article Volume 12 Issue 10 Page(s) 815-816
Citation(s):
  • Gabriel M. Lentner, Litigating Patents in Investment Arbitration: Eli Lilly v. Canada, 12 Journal of Intellectual Property Law & Practice 815 (2017).
Related Organization(s):

Abstract

Eli Lilly and Company v. Government of Canada, Final Award, UNCITRAL, ICSID Case No. UNCT/14/2, 16 March 2017

For the first time in investment arbitration, a tribunal has ruled in a case involving the invalidation of a pharmaceutical company’s patents by Canadian courts in an investment-based claim.